NRX PHARMACEUTICALS

Lobbying client · Delaware · filed 2025 to 2026

Clinical biopharma company

$265,323 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (68511), not by name.

Firms hired 1

CONTINENTAL STRATEGY, LLC $265,323 5 filings

Reported by year 2 years

2026 $150,000 2 filings
2025 $115,323 3 filings

Issues lobbied 1

Pharmacy 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Health & Human Services, Dept of (HHS) 4
Executive Office of the President (EOP) 2
HOUSE OF REPRESENTATIVES 2

Recent filings 5 total

Q2

CONTINENTAL STRATEGY, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · $75,000 income · posted Jul 19, 2026

View → Q1

CONTINENTAL STRATEGY, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · $75,000 income · posted Apr 18, 2026

View → Q4

CONTINENTAL STRATEGY, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · $75,000 income · posted Jan 19, 2026

View → Q3

CONTINENTAL STRATEGY, LLC

3rd Quarter (July 1 - Sep 30) 2025 · $40,323 income · posted Oct 20, 2025

View → RR

CONTINENTAL STRATEGY, LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Aug 28, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.